1-2 of 2
Masami Oyama, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Response Rate and Acceptable Toxicity of R-P-Imvp-16/CBDCA for Relapsed or Refractory Aggressive B-Cell Lymphoma

Takuro Matsumoto, MD, Nobuhiko Nakamura, MD PhD, Yuhei Shibata, MD, Hiroshi Nakamura, MD, Ryoko Mabuchi, MD, Junichi Kitagawa, MD PhD, Nobuhiro Kanemura, MD PhD, Naoe Goto, MD PhD, Senji Kasahara, MD PhD, Hideko Goto, MD PhD, Kenji Fukuno, MD PhD, Takeshi Hara, MD PhD, Toshiki Yamada, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MD PhD, Masami Oyama, MD PhD, Koshiro Saito, MD PhD, Hisashi Tsurumi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4418.
https://doi.org/10.1182/blood.V124.21.4418.4418
Published: 2014
Journal Articles

Serum-Soluble Tumor Necrosis Factor Receptor 2 (sTNF-R2) Level Determines Clinical Outcome in Patients with Aggressive Non-Hodgkin’s Lymphoma.

Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, Masao Takemura, PhD, Takeshi Hara, MD, PhD, Michio Sawada, MD, PhD, Toshiki Yamada, MD, PhD, Senji Kasahara, MD, PhD, Nobuhiro Kanemura, MD, Takeshi Takahashi, MD, PhD, Masami Oyama, MD, PhD, Eiichi Tomita, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3271.
https://doi.org/10.1182/blood.V104.11.3271.3271
Published: 2004